Benign Karaciğer Hastalıklarında Endoskopik Ultrason Eşliğinde İnce İğne Aspirasyonu: Tek Merkez Deneyimi

Year 2023, Volume: 22 Issue: 1, 1 - 5, 30.04.2023

Salih Tokmak , Sinem Coşkun Kantarcıoğlu , Serkan Torun

https://doi.org/10.17941/agd.1255462

Abstract

Giriş ve Amaç: Endoskopik ultrason kılavuzluğunda karaciğer biyopsisi (EUS-LB) ile ilgili ilk deneyimimizin etkinlik ve güvenlik sonuçlarını bildirmek.

Gereç ve Yöntem: Üçüncü basamak merkezimizde, ileriye dönük olarak tutulan bir veri tabanının geriye dönük analizi yapıldı. Haziran 2022 ile Aralık 2022 tarihleri ​​arasında, benign parankimal hastalıklar nedeniyle, tek geçişli, üç hamleli ve ıslak aspirasyon tekniği ve 19 gauge ince iğne kullanılarak EUS-LB uygulanan ardışık hastalar çalışmaya dahil edildi. Hastaların demografik bilgileri, işlem ile ilgili parametreler ve örneklerin kalitesi değerlendirildi.

Sonuçlar: Teknik başarı %100 idi. Toplam 16 hastadan dördüne yetersiz örnekleme nedeniyle ikinci kez işlem uygulandı. Medyan toplam numune uzunluğu, medyan parça sayısı ve parçalanmış numunelerdeki en uzun parçanın medyan uzunluğu ve tam portal yolların medyan sayısı sırayla 11 mm (aralık, 0,2-2,5), 9,6 (aralık, 0-20), 0,2mm (aralık 0,2-1,5) ve 3,5 (aralık 0-19) olarak bulundu. İşlem sonrası hiçbir hastada yan etki görülmedi.

Sonuç: EUS-LB, diğer karaciğer biyopsi prosedürlerine bir alternatif olabilir, ancak ideal iğne tipini ve tekniğini belirlemek için daha fazla çalışmaya ihtiyaç vardır.

Keywords

endoskopik ultrasonografi, ince iğne aspirasyon biyopsisi, karaciğer hastalıkları

Supporting Institution

Yok

Project Number

Yok

Thanks

Yok

Endoscopic Ultrasound-guided Fine Needle Aspiration for Benign Liver Diseases: Single-center Experience

Abstract

Background and Aim: To report the efficacy and safety results of our initial experience with the endoscopic ultrasound-guided liver biopsy (EUS-LB).

Materials and Method: Retrospective analysis of a prospectively maintained database in a tertiary care referral center. Consecutive patients who had EUS-LB for benign parenchymal diseases, using a 19 gauge fine needle with single-pass, three actuations, and wet suction technique between June 2022 and December 2022 were included. Patient demographics, procedure-related parameters, and the quality of specimens were investigated

Results: The technical success was 100%. Of the 16 patients, four had a second procedure due to inadequate sampling. The median total sample length, the median number of pieces and the median length of the longest piece in fragmented samples, and the median number of complete portal tracts were 11mm (range, 0.2-2.5), 9.6 (range 0-20), 0.2mm (range 0.2-1.5) and 3.5 (range 0-19) respectively. None of the patients had any adverse events following the procedure.

Conclusion: EUS-LB may be an alternative to other liver biopsy procedures but further studies are needed to determine the ideal needle type and technique.

Keywords

endoscopic ultrasonography, fine needle aspiration biopsy, liver diseases

Project Number

Yok

References

• [1] Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD; American Association for the Study of Liver Diseases. Liver biopsy. Hepatology 2009;49:1017-44.
• [2] Kalambokis G, Manousou P, Vibhakorn S, et al. Transjugular liver biopsy--indications, adequacy, quality of specimens, and complications--a systematic review. J Hepatol 2007;47:284-94.
• [3] Meng HC, Lin HC, Huang CC, et al. Transjugular liver biopsy: comparison with percutaneous liver biopsy. J Gastroenterol Hepatol 1994;9:457-61.
• [4] Diehl DL, Johal AS, Khara HS, et al. Endoscopic ultrasound-guided liver biopsy: a multicenter experience. Endosc Int Open 2015;3:E210-5.
• [5] Rangwani S, Ardeshna DR, Mumtaz K, et al. Update on endoscopic ultrasound-guided liver biopsy. World J Gastroenterol 2022;28:3586-94.
• [6] Pineda JJ, Diehl DL, Miao CL, et al. EUS-guided liver biopsy provides diagnostic samples comparable with those via the percutaneous or transjugular route. Gastrointest Endosc 2016;83:360-5.
• [7] Aldrete JA. The post-anesthesia recovery score revisited. J Clin Anesth 1995;7:89-91.
• [8] Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344:495-500.
• [9] Mathew A. EUS-guided routine liver biopsy in selected patients. Am J Gastroenterol 2007;102:2354-5.
• [10] Ching-Companioni RA, Johal AS, Confer BD, et al. Single-pass 1-needle actuation versus single-pass 3-needle actuation technique for EUS-guided liver biopsy sampling: a randomized prospective trial (with video). Gastrointest Endosc 2021;94:551-8.
• [11] Mohan BP, Shakhatreh M, Garg R, Ponnada S, Adler DG. Efficacy and safety of EUS-guided liver biopsy: a systematic review and meta-analysis. Gastrointest Endosc 2019;89:238-46.
• [12] Ching-Companioni RA, Diehl DL, Johal AS, Confer BD, Khara HS. 19 G aspiration needle versus 19 G core biopsy needle for endoscopic ultrasound-guided liver biopsy: a prospective randomized trial. Endoscopy 2019;51:1059-65.
• [13] Baran B, Kale S, Patil P, et al. Endoscopic ultrasound-guided parenchymal liver biopsy: a systematic review and meta-analysis. Surg Endosc 2021;35:5546-57.
• [14] Zeng K, Jiang Z, Yang J, Chen K, Lu Q. Role of endoscopic ultrasound-guided liver biopsy: a meta-analysis. Scand J Gastroenterol 2022;57:545-57.
• [15] Stavropoulos SN, Im GY, Jlayer Z, et al. High yield of same-session EUS-guided liver biopsy by 19-gauge FNA needle in patients undergoing EUS to exclude biliary obstruction. Gastrointest Endosc 2012;75:310-8.
• [16] Malik AH, Kumar KS, Malet PF, et al. Correlation of percutaneous liver biopsy fragmentation with the degree of fibrosis. Aliment Pharmacol Ther 20041;19:545-9.